The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global SNP Genotyping and Analysis Market Research Report 2025

Global SNP Genotyping and Analysis Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1556620

No of Pages : 89

Synopsis
A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.
The global SNP Genotyping and Analysis market was valued at US$ 1457 million in 2023 and is anticipated to reach US$ 4130.9 million by 2030, witnessing a CAGR of 16.8% during the forecast period 2024-2030.
Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.
This report aims to provide a comprehensive presentation of the global market for SNP Genotyping and Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SNP Genotyping and Analysis.
Report Scope
The SNP Genotyping and Analysis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SNP Genotyping and Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SNP Genotyping and Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
Agilent Technologies
Roche
Bio-rad
LGC
Sequenom
Beckman Coulter
QIAGEN
Fluidigm
Segment by Type
Dynamic Allele-Specific Hybridization
Molecular Beacons
SNP Microarrays
Segment by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Breeding and Animal Livestock
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SNP Genotyping and Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SNP Genotyping and Analysis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dynamic Allele-Specific Hybridization
1.2.3 Molecular Beacons
1.2.4 SNP Microarrays
1.3 Market by Application
1.3.1 Global SNP Genotyping and Analysis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals and Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Agricultural Biotechnology
1.3.5 Breeding and Animal Livestock
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global SNP Genotyping and Analysis Market Perspective (2019-2030)
2.2 SNP Genotyping and Analysis Growth Trends by Region
2.2.1 Global SNP Genotyping and Analysis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 SNP Genotyping and Analysis Historic Market Size by Region (2019-2024)
2.2.3 SNP Genotyping and Analysis Forecasted Market Size by Region (2025-2030)
2.3 SNP Genotyping and Analysis Market Dynamics
2.3.1 SNP Genotyping and Analysis Industry Trends
2.3.2 SNP Genotyping and Analysis Market Drivers
2.3.3 SNP Genotyping and Analysis Market Challenges
2.3.4 SNP Genotyping and Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top SNP Genotyping and Analysis Players by Revenue
3.1.1 Global Top SNP Genotyping and Analysis Players by Revenue (2019-2024)
3.1.2 Global SNP Genotyping and Analysis Revenue Market Share by Players (2019-2024)
3.2 Global SNP Genotyping and Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by SNP Genotyping and Analysis Revenue
3.4 Global SNP Genotyping and Analysis Market Concentration Ratio
3.4.1 Global SNP Genotyping and Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SNP Genotyping and Analysis Revenue in 2023
3.5 SNP Genotyping and Analysis Key Players Head office and Area Served
3.6 Key Players SNP Genotyping and Analysis Product Solution and Service
3.7 Date of Enter into SNP Genotyping and Analysis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SNP Genotyping and Analysis Breakdown Data by Type
4.1 Global SNP Genotyping and Analysis Historic Market Size by Type (2019-2024)
4.2 Global SNP Genotyping and Analysis Forecasted Market Size by Type (2025-2030)
5 SNP Genotyping and Analysis Breakdown Data by Application
5.1 Global SNP Genotyping and Analysis Historic Market Size by Application (2019-2024)
5.2 Global SNP Genotyping and Analysis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America SNP Genotyping and Analysis Market Size (2019-2030)
6.2 North America SNP Genotyping and Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America SNP Genotyping and Analysis Market Size by Country (2019-2024)
6.4 North America SNP Genotyping and Analysis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe SNP Genotyping and Analysis Market Size (2019-2030)
7.2 Europe SNP Genotyping and Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe SNP Genotyping and Analysis Market Size by Country (2019-2024)
7.4 Europe SNP Genotyping and Analysis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific SNP Genotyping and Analysis Market Size (2019-2030)
8.2 Asia-Pacific SNP Genotyping and Analysis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific SNP Genotyping and Analysis Market Size by Region (2019-2024)
8.4 Asia-Pacific SNP Genotyping and Analysis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America SNP Genotyping and Analysis Market Size (2019-2030)
9.2 Latin America SNP Genotyping and Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America SNP Genotyping and Analysis Market Size by Country (2019-2024)
9.4 Latin America SNP Genotyping and Analysis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa SNP Genotyping and Analysis Market Size (2019-2030)
10.2 Middle East & Africa SNP Genotyping and Analysis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa SNP Genotyping and Analysis Market Size by Country (2019-2024)
10.4 Middle East & Africa SNP Genotyping and Analysis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific SNP Genotyping and Analysis Introduction
11.1.4 Thermo Fisher Scientific Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina SNP Genotyping and Analysis Introduction
11.2.4 Illumina Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies SNP Genotyping and Analysis Introduction
11.3.4 Agilent Technologies Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche SNP Genotyping and Analysis Introduction
11.4.4 Roche Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Bio-rad
11.5.1 Bio-rad Company Detail
11.5.2 Bio-rad Business Overview
11.5.3 Bio-rad SNP Genotyping and Analysis Introduction
11.5.4 Bio-rad Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.5.5 Bio-rad Recent Development
11.6 LGC
11.6.1 LGC Company Detail
11.6.2 LGC Business Overview
11.6.3 LGC SNP Genotyping and Analysis Introduction
11.6.4 LGC Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.6.5 LGC Recent Development
11.7 Sequenom
11.7.1 Sequenom Company Detail
11.7.2 Sequenom Business Overview
11.7.3 Sequenom SNP Genotyping and Analysis Introduction
11.7.4 Sequenom Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.7.5 Sequenom Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Detail
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter SNP Genotyping and Analysis Introduction
11.8.4 Beckman Coulter Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.8.5 Beckman Coulter Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Detail
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN SNP Genotyping and Analysis Introduction
11.9.4 QIAGEN Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.9.5 QIAGEN Recent Development
11.10 Fluidigm
11.10.1 Fluidigm Company Detail
11.10.2 Fluidigm Business Overview
11.10.3 Fluidigm SNP Genotyping and Analysis Introduction
11.10.4 Fluidigm Revenue in SNP Genotyping and Analysis Business (2019-2024)
11.10.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’